切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2020, Vol. 14 ›› Issue (05) : 384 -387. doi: 10.3877/cma.j.issn.1674-0793.2020.05.018

所属专题: 文献

综述

甲状腺乳头状癌颈侧区淋巴结转移的危险因素研究进展
郑福庆1, 张立永1, 王波1, 颜守义1, 赵文新1,()   
  1. 1. 350001 福州,福建医科大学附属协和医院血管与甲状腺外科
  • 收稿日期:2019-01-30 出版日期:2020-10-01
  • 通信作者: 赵文新
  • 基金资助:
    福建省医学创新课题(2018-CX-17); 福建省卫生计生委青年科研课题(2017-2-22); 福建医科大学启航基金项目(2017XQ1037)

Research progress in risk factors of lateral lymph node metastasis in papillary thyroid carcinoma

Fuqing Zheng1, Liyong Zhang1, Bo Wang1, Shouyi Yan1, Wenxin Zhao1,()   

  1. 1. Department of Vascular and Thyroid Surgery, Fujian Medical University Union Hospital, Fuzhou 350001, China
  • Received:2019-01-30 Published:2020-10-01
  • Corresponding author: Wenxin Zhao
  • About author:
    Corresponding author: Zhao Wenxin, Email:
引用本文:

郑福庆, 张立永, 王波, 颜守义, 赵文新. 甲状腺乳头状癌颈侧区淋巴结转移的危险因素研究进展[J/OL]. 中华普通外科学文献(电子版), 2020, 14(05): 384-387.

Fuqing Zheng, Liyong Zhang, Bo Wang, Shouyi Yan, Wenxin Zhao. Research progress in risk factors of lateral lymph node metastasis in papillary thyroid carcinoma[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2020, 14(05): 384-387.

颈侧区淋巴结转移(LLNM)是甲状腺乳头状癌(PTC)患者术后预后不良的重要预测因素。手术前LLNM的漏诊将增加复发风险以及伴随的二次手术。对于具有LLNM危险因素的PTC患者,应放宽颈侧区肿大淋巴结穿刺活检指征,有助于术前发现更多隐匿的颈侧区转移淋巴结,制定更恰当的颈部淋巴结清扫范围。因此,本文就PTC患者LLNM规律及危险因素作一综述。

Lateral lymph node metastasis is an important predictor of poor prognosis in patients with papillary thyroid carcinoma (PTC). Missed diagnosis of lateral lymph node metastasis before surgery will increase the risk of recurrence and the accompanying secondary surgery. For the enlarged lateral lymph nodes of PTC patients with risk factors, it may be recommended to extend the indications of fine-needle aspiration cytology to find out more occult metastatic lateral lymph nodes and develop a more appropriate range of cervical lymph node dissection. Thus, this article reviews the pattern and risk factors of lateral lymph node metastasis in PTC.

[1]
Aydin Buyruk B, Kebapci N, Yorulmaz G, et al. An evaluation of clinicopathological factors effective in the development of central and lateral lymph node metastasis in papillary thyroid cancer[J]. J Natl Med Assoc, 2018, 110(4): 384-390.
[2]
Xing M, Alzahrani AS, Carson KA, et al. Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer[J]. JAMA, 2013, 309(14): 1493-1501.
[3]
Zhang TT, Qi XZ, Chen JP, et al. The association between tumor’s location and cervical lymph nodes metastasis in papillary thyroid cancer[J]. Gland Surg, 2019, 8(5): 557-568.
[4]
Leboulleux S, Rubino C, Baudin E, et al. Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis[J]. J Clin Endocrinol Metab, 2005, 90(10): 5723-5729.
[5]
Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer[J]. Thyroid, 2016, 26(1): 1-133.
[6]
陈锐, 魏涛, 张明, 等. 甲状腺乳头状癌cN0患者颈侧区淋巴结转移规律的探讨[J]. 中华耳鼻咽喉头颈外科杂志, 2012, 47(8): 662-667.
[7]
Likhterov I, Reis LL, Urken ML. Central compartment management in patients with papillary thyroid cancer presenting with metastatic disease to the lateral neck: anatomic pathways of lymphatic spread[J]. Head Neck, 2017, 39(5): 853-859.
[8]
鄢丹桂, 张彬, 安常明, 等. 甲状腺乳头状癌临床N0患者颈部淋巴结转移规律[J] . 中华耳鼻咽喉头颈外科杂志, 2011, 46(11): 887-891.
[9]
Lei J, Zhong J, Jiang K, et al. Skip lateral lymph node metastasis leaping over the central neck compartment in papillary thyroid carcinoma[J]. Oncotarget, 2017, 8(16): 27022-27033.
[10]
Park JH, Lee YS, Kim BW, et al. Skip lateral neck node metastases in papillary thyroid carcinoma[J]. World J Surg, 2012, 36(4): 743-747.
[11]
Jin WX, Jin YX, Ye DR, et al. Predictive factors of skip metastasis in papillary thyroid cancer[J]. Med Sci Monit, 2018, 24: 2744-2749.
[12]
Lee YS, Shin SC, Lim YS, et al. Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer[J]. Head Neck, 2014, 36(6): 887-891.
[13]
Wang W, Gu J, Shang J, et al. Correlation analysis on central lymph node metastasis in 276 patients with cN0 papillary thyroid carcinoma[J]. Int J Clin Exp Pathol, 2013, 6(3): 510-515.
[14]
Lee YS, Jeong JJ, Nam KH, et al. Papillary carcinoma located in the thyroid isthmus[J]. World J Surg, 2010, 34(1): 36-39.
[15]
Edge SB, Byrd DR, Comp CC, et al. AJCC Cancer Staging Manual[M]. 8th ed. New York: Springer, 2017.
[16]
Ito Y, Higashiyama T, Takamura Y, et al. Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection[J]. World J Surg, 2007, 31(11): 2085-2091.
[17]
Patron V, Hitier M, Bedfert C, et al. Predictive factors for lateral occult lymph node metastasis in papillary thyroid carcinoma[J]. Eur Arch Otorhinolaryngol, 2013, 270(7): 2095-2100.
[18]
So YK, Kim MJ, Kim S, et al. Lateral lymph node metastasis in papillary thyroid carcinoma: A systematic review and Meta-analysis for prevalence, risk factors, and location[J]. Int J Surg, 2018, 50: 94-103.
[19]
陈万青, 李贺, 孙可欣, 等. 2014年中国恶性肿瘤发病和死亡分析[J]. 中华肿瘤杂志, 2018, 40(1): 5-13.
[20]
Kim SK, Park I, Woo JW, et al. Predictive factors for lymph node metastasis in papillary thyroid microcarcinoma[J]. Ann Surg Oncol, 2016, 23(9): 2866-2873.
[21]
Zhao W, Chen S, Hou X, et al. Predictive factors of lateral lymph node metastasis in papillary thyroid microcarcinoma[J]. Pathol Oncol Res, 2019, 25(3): 1245-1251.
[22]
Ryu YJ, Kang SJ, Cho JS, et al. Identifying risk factors of lateral lymph node recurrence in clinically node-negative papillary thyroid cancer[J]. Medicine (Baltimore), 2018, 97(51): e13435.
[23]
孟庆东. 多灶性甲状腺乳头状癌的临床特征及淋巴结转移因素分析[D]. 长春:吉林大学, 2018.
[24]
孟庆东, 边学海, 孙辉, 等. 多灶性甲状腺乳头状癌的诊疗进展[J]. 中国普通外科杂志, 2016, 25(11): 1640-1645.
[25]
王刚平, 张红, 武杰, 等. 多灶性甲状腺乳头状癌生物学行为分析[J]. 山东医药, 2011, 51(29): 72-73.
[26]
殷德涛, 韩飏, 张亚原, 等. 多灶性甲状腺乳头状癌的临床病理及颈淋巴结转移特征[J]. 中国普通外科杂志, 2017, 26(5): 556-560.
[27]
Wang W, Su X, He K, et al. Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2 000 consecutive patients[J]. Cancer, 2016, 122(2): 198-206.
[28]
王伟斌, 苏星韵, 阮佳莹, 等. 2 682例甲状腺乳头状癌临床病理及预后分析[J]. 中华普通外科杂志, 2018, 33(5): 393-397.
[29]
赵敬柱. 甲状腺乳头状癌侧颈淋巴结转移的危险因素分析[C]//中国抗癌协会甲状腺癌专业委员会,中国抗癌协会头颈肿瘤专业委员会,中华医学会肿瘤分会头颈学组. 2014第六届全国甲状腺肿瘤学术大会论文集.天津,2014: 340-346.
[30]
Zeng RC, Zhang W, Gao EL, et al. Number of central lymph node metastasis for predicting lateral lymph node metastasis in papillary thyroid microcarcinoma[J]. Head Neck, 2014, 36(1): 101-106.
[1] 孙莲, 马红萍, 吴文英. 局部进展期甲状腺癌患者外科处理[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 112-114.
[2] 麻紫月, 王贞文, 张强, 赵代伟, 张翊伦. 右侧喉不返神经1例报告[J/OL]. 中华普外科手术学杂志(电子版), 2025, 19(01): 115-116.
[3] 顾雯, 凌守鑫, 唐海利, 甘雪梅. 两种不同手术入路在甲状腺乳头状癌患者开放性根治性术中的应用比较[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 687-690.
[4] 贺斌, 马晋峰. 胃癌脾门淋巴结转移危险因素[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(06): 694-699.
[5] 王宇, 徐芳泉, 周旋, 姚晓峰, 李强. 不断提高分化型甲状腺癌根治性切除规范化[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 473-476.
[6] 孙辉, 李长霖. 分化型甲状腺癌根治性切除术中的关键考量与策略[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 477-481.
[7] 高一飞, 刘根祥, 孙长华, 周广军. 喉返神经监测在无充气腋窝入路腔镜单侧甲状腺切除+中央区淋巴结清扫术中的应用效果[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 483-486.
[8] 李云龙, 夏旭良, 江志强, 刘伟, 刘凯, 唐立, 刘昊中, 张思远. 三种方法治疗分化型甲状腺癌的临床疗效[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 487-489.
[9] 韩婧, 郝少龙, 康骅. 北京市单中心甲状腺癌患者临床特征的回顾分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(05): 490-493.
[10] 林逸, 钟文龙, 李锴文, 何旺, 林天歆. 广东省医学会泌尿外科疑难病例多学科会诊(第15期)——转移性膀胱癌的综合治疗[J/OL]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(06): 648-652.
[11] 林凯, 潘勇, 赵高平, 杨春. 造口还纳术后切口疝的危险因素分析与预防策略[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 634-638.
[12] 杨闯, 马雪. 腹壁疝术后感染的危险因素分析[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 693-696.
[13] 颜世锐, 熊辉. 感染性心内膜炎合并急性肾损伤患者的危险因素探索及死亡风险预测[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 618-624.
[14] 刘志超, 胡风云, 温春丽. 山西省脑卒中危险因素与地域的相关性分析[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 424-433.
[15] 曹亚丽, 高雨萌, 张英谦, 李博, 杜军保, 金红芳. 儿童坐位不耐受的临床进展[J/OL]. 中华脑血管病杂志(电子版), 2024, 18(05): 510-515.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?